The European Economic and Social Committee (EESC) is a consultative body that gives representatives of Europe's socio-occupational interest groups, and others, a formal platform to express their points of views on EU issues. Its opinions are forwarded to the larger institutions - the Council, the Commission and the European Parliament. It thus has a key role to play in the Union's decision-making process.
The ERC is the first European funding body set up to support investigator-driven frontier research. Its main aim is to stimulate scientific excellence by supporting and encouraging the very best, truly creative scientists, scholars and engineers to be adventurous and take risks in their research. The scientists are encouraged to go beyond established frontiers of knowledge and the boundaries of disciplines.
With effect from 1 January 2014, the Trans-European Transport Network Executive Agency (TEN-T EA), which was set up by the European Commission in 2006 to manage the technical and financial implementation of its TEN-T programme, has become the Innovation and Networks Executive Agency (INEA). INEA’s mission is to implement parts of the EU programmes: Connecting Europe Facility (CEF), Horizon 2020 and the legacy programmes: TEN-T and Marco Polo 2007-2013.
On 8 December, the Centre signed an agreement with the Single Resolution Board (SRB). Based in Brussels, this newly-created EU agency has been operational as of 1 January 2015.
A refinement of scope has become effective for the Executive Agency for Competitiveness and Innovation, which, with effect from 1 January 2014, is now called Executive Agency for Small and Medium-sized enterprises (EASME).
The Council is the main decision-making body of the European Union. The Council is responsible for decision-making and co-ordination. The acts of the Council can take the form of regulations, directives, decisions, common actions or common positions, recommendations or opinions. The Council can also adopt conclusions, declarations or resolutions.
The IMI is a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The aim of IMI is to support the faster discovery and development of better medicines for patients and to enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic high-technology sector.
The Fuel Cells and Hydrogen Joint Undertaking is a unique public private partnership supporting research, technological development and demonstration (RTD) activities in fuel cell and hydrogen energy technologies in Europe. Its aim is to accelerate the market introduction of these technologies, realising their potential as an instrument in achieving a carbon-lean energy system.
The EDPS’ general objective is to ensure that the EU institutions and bodies respect the right to privacy when they process personal data and develop new policies.
On 6 May 2014, the Council of the European Union adopted the Regulation establishing the ECSEL Joint Undertaking. This new organisation replaces ARTEMIS JU and ENIAC JU. ECSEL JU has become operational as of 27 June 2014.